Impact of Lot-to-Lot Variability of Cation Exchange Chromatography Resin on Process Performance - A case study to understand the impact of lot-to-lot variability of a cation exchange resin on process

ADVERTISEMENT

Impact of Lot-to-Lot Variability of Cation Exchange Chromatography Resin on Process Performance
A case study to understand the impact of lot-to-lot variability of a cation exchange resin on process performance.


BioPharm International
Volume 21, Issue 5

REFERENCES

1. Ishihara T, Kadoya T. Accelerated purification process development of monoclonal antibodies for shortening time to clinic. Design and case study of chromatography processes. J Chromatogr A. 2007 Dec 28;1176(1–2):149–156.

2. Yamamoto S, Nomura M, Sano Y. Stepwise elution chromatography as a method for both purification and concentration of proteins. Chem Eng Sci. 1992 Jan;47(1):185–188.

3. DiLeo M, Haimes E, Ley A, Chen J. Interaction of Resin-Buffer-Antibody Product Influences the development of an optimal cation exchange purification process for specific monoclonal antibody products. Dyax Corporation. 2007.

4. Cabanne C, Raedts M, Zavadzky E, Santarelli X. Evaluation of radial chromatography versus axial chromatography, practical approach. J Chromatogr B. 2007 Jan 15;845(2):191–199.

5. Janson JC, Ryden L. Protein purification-principles, high resolution methods, and applications. New York: Wiley-VHC; 1998.

6. Carta G, Ubiera A. Particle size distribution effects in batch adsorption. AICHE J. 2004;49(12):3066–3073.

7. Karau A, Benknen C, Thommes J, Kula MR. The influence of particle size distribution and operating conditions on the adsorption performance in fluidized beds. Biotechnol Bioeng. 1997 Jul 5:55(1):54–64.

8. Billen J, Davy D, Rudaz S, Veuthey JL, Ritchie H, Grady B, Desmet G. Relation between the particle size distribution and the kinetic performance of packed columns: Application to a commercial sub-2 μm particle material. J Chromatogr A. 2007 Aug 17;1161(1–2):224–233.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here